Adaptation of Group A Streptococcu s to Human Amniotic Fluid Authors: Izabela Sitkiewicz, Nicole M. Green, Nina Guo, Ann M. Bongiovanni, Steven S. Witkin, James M. Musser Published: 2010, PLOS ONE DOI: 10.1371/journal.pone.0009785 ABSTRACT For more than 100 years, group A Streptococcus has been identified as a cause of severe and, in many cases, fatal infections of the female urogenital tract. Due to advances in hospital hygiene and the advent of antibiotics, this type of infection has been virtually eradicated. However, within the last three decades there has been an increase in severe intra- and post-partum infections attributed to GAS. We hypothesized that GAS alters its transcriptome to survive in human amniotic fluid (AF) and cause disease. To identify genes that were up or down regulated in response to growth in AF, GAS was grown in human AF or standard laboratory media (THY) and samples for expression microarray analysis were collected during mid-logarithmic, late-logarithmic, and stationary growth phases. Microarray analysis was performed using a custom Affymetrix chip and normalized hybridization values derived from three biological replicates were collected at each growth point. Ratios of AF/THY above a 2-fold change and P-value <0.05 were considered significant. The majority of changes in the GAS transcriptome involved down regulation of multiple adhesins and virulence factors and activation of the stress response. We observed significant changes in genes involved in the arginine deiminase pathway and in the nucleotide de novo synthesis pathway. Our work provides new insight into how pathogenic bacteria respond to their environment to establish infection and cause disease. INTRODUCTION Group A Streptococcus ( Streptococcus pyogenes , GAS) is an exclusively human, Gram-positive pathogen that causes a broad variety of diseases from mild pharyngitis and skin infections to necrotizing fasciitis, streptococcal toxic shock syndrome, and non-suppurative sequelae such as acute rheumatic fever or glumerulonephritis (for a review see [1] ). Since the 1980's, GAS has re-emerged as an important cause of severe invasive infections and is estimated to cause approximately 500,000 deaths each year globally despite available antibiotic treatment [2] . In the late 1800's, GAS was identified as a causative factor of puerperal sepsis – a severe invasive infection in post partum women [3] . Due to advances in hospital hygiene, namely physicians washing their hands between deliveries, these types of GAS infections became less frequent. However, in the last three decades there has been a resurgence in GAS infections of the female urogenital tract and vulvovaginatis in pre-pubescent females, and invasive postpartum disease now accounts for approximately 2.2% of invasive GAS diseases [4] . Women with pre-existing throat infections or disrupted mucosal and skin barriers during pregnancy and delivery are particularly susceptible [4] . GAS strains are classified based on the aminoterminal sequence of the M protein, a polymorphic cell surface adhesin and anti-phagocytic factor [1] . Among the various GAS serotypes, serotype M28 strains are a common cause of invasive disease and have an unusual propensity to cause vaginitis and postpartum infections [4] – [6] . Full-genome sequence analysis of an M28 strain provided the first insight into the underlying molecular mechanism for the ability of these strains to cause a disproportionate number of postpartum infections [5] . Green et al. identified a mobile genetic element, named Region of Difference (RD) 2, that was present in all serotype M28 strains analyzed and a subset of other M serotype strains that have been linked epidemiologically to maternal-neonatal infections [5] . Interestingly, RD2 shares extensive similarity with regions in group B Streptococcus ( Streptococcus agalactiae , GBS) [5] , [7] , which is a common cause of female urogenital tract infections, and genes in groups C and G Streptococcus (Sitkiewicz I., Green NM., and Musser JM, unpublished) that can also cause severe invasive infections [8] , [9] . As mentioned previously, GAS is capable of causing a wide range of diseases by successfully colonizing a variety of anatomical sites. Transcriptome analyses of GAS grown in blood, saliva, epithelial cells, and polymorphonuclear leukocytes (PMNs) have revealed that GAS is extremely adaptable and modifies its transcriptome based on environmental signals [10] – [13] . To establish infection in the female urogenital tract, GAS must survive and replicate in a bacteriostatic host environment. The ability of GBS to persist and replicate in human amniotic fluid (AF) [14] is an important contributing factor to its ability to cause severe pre- and postpartum infections, despite AF having antibiotic properties towards other bacterial species [15] . Because M28 GAS strains contain the RD2 element and cause a disproportionate number of postpartum infections, we hypothesized that serotype M28 GAS would be able to survive and persist in human AF, similarly to GBS. To initially characterize the interaction of pathogenic GAS within this specific host niche, we used an ex vivo strategy to analyze the global transcriptional response of GAS grown in human AF compared to GAS grown under standard laboratory conditions. MATERIALS AND METHODS GAS strains MGAS6180 (serotype M28, RD2+) [5] , and MGAS 5005 (serotype M1, RD2-) [16] were grown in Todd Hewitt medium with 0.5% yeast extract or on TSA II plates supplemented with 5% sheep blood (BD Diagnostics) at 37°C in 5% CO 2 . GROWTH OF BACTERIA IN AF Human (AF) was collected from pregnant women seen at The Methodist Hospital, Houston, Texas, or Weill Medical College of Cornell University in New York City. Samples were collected in accordance with an exempt human subjects protocol approved by the Institution Review Board of each institution. The study involved collection of existing diagnostic specimens routinely collected during clinical procedures as amniocenteses and would have been otherwise discarded. Specimens were stripped of all identifiers and processed in a manner that subjects cannot be directly or indirectly identified. AF samples were tested to determine if they supported bacterial growth. GAS cells were grown overnight in THY, washed twice in sterile PBS, and re-suspended in PBS to 100×. Ten µl of the 100× bacteria suspension were diluted further in PBS and were used to inoculate each 250 µl sample of heat inactivated (95°C, 5 min) AF, resulting in a final average inoculum of ∼10 4 CFU/ml. Samples were incubated at 37°C with 5% CO 2 for 24 h. To avoid THY carryover that might bias the growth results, bacteria were diluted 1∶50 or 1∶25 into a fresh aliquot of AF after the first 24 h. Aliquots were removed, serially diluted, and plated on TSA II plates (BD Diagnostics) every hour for the first 12 h and every 12 h thereafter for CFU enumeration. AF samples that supported growth of GAS were pooled and used for the microarray analysis. Samples were collected from three pooled AF cultures (biological replicates) after 3.5, 5, and 9 hours of growth in AF, which corresponds to bacteria in mid log (ML) growth phase, late log (LL, time point corresponding with the transition from log to stationary phase) and stationary (S) phase, respectively. Bacteria grown in THY laboratory medium were collected in ML, LL and S phase from three independent cultures (biological replicates). RNA ISOLATION The bacteria used for RNA isolation were mixed with 2 volumes of RNA Protect reagent (Qiagen) and cells were collected by centrifugation and stored at −80°C until processing. RNA from GAS was isolated as described previously [17] . All samples were processed at the same time to minimize experimental error. Reverse transcription, cDNA fragmentation, and labeling for all samples were performed as described previously [17] . MICROARRAY ANALYSIS Microarray analysis was performed using a custom-made Affymetrix chip [18] that contained 1929 redundant probes representing the core GAS chromosome and 289 redundant probes unique for MGAS6180. A total of 1765 MGAS6180 genes were represented on the array. Chip hybridization and data acquisition and processing were performed as described [19] . Samples used for microarray analysis were collected from cultures in THY and AF at mid logarithmic (ML), late logarithmic (LL) and stationary (S) growth phases. The average expression values for each transcript in AF in each growth phase was divided by the average expression in THY to generate AF/THY ratios and degree of changes. Genes that had a two-fold change of expression or greater in AF and were statistically significant (P<0.05) were included in the analysis. The data is deposited in MIAME-compliant GEO database under accession number GSE19985. RESULTS AND DISCUSSION Human AF is a nutritionally poor environment. AF is composed primarily of water and low amounts of sugars and proteins, levels of which decrease as the pregnancy nears term [20] . Recent detailed compositional analysis of AF revealed the presence of multiple proteins (serum albumin, transferrin, α-I-Antitripsin, α-fetoprotein, calpain 6, pinin, type XIII collagen, immunoglobulins) [21] , glucose, fructose, lipids, hormones (estrogen and progesterone), and epithelial cells. Sources of AF are predominantly fetal urine (∼900 ml per day influx at term), tracheal fluid, fetal lung fluid, and water and solvents transferred between AF and fetal blood in placenta [22] . GAS rarely causes septic abortions [4] ; however, after disruption of membranes, release of AF can change the environment of the female genital tract by increasing pH from acidic to neutral/slightly alkaline and affect balance of natural bacterial vaginal flora. GAS grows better in neutral than acidic pH [23] , therefore pH change can promote growth of colonizing pathogens and postpartum infection. Because GAS is able to cause postpartum infections suggests that it is able to survive in an environment containing AF. Individual specimens of AF collected from women at various stages of pregnancy can vary in their bacteriostatic properties, primarily due to the activity of lysozyme, immunoglobins, and β−lysin [24] – [26] . In general, samples from early stage pregnancies are less bacteriostatic than samples from late stage pregnancies [27] . In addition, bacteriostatic properties of AF also depend on the presence of meconium and iron availability [28] . Often the presence of meconium in AF is used to predict the likelihood of the mother developing a postpartum or intrapartum bacterial infection [29] . Therefore we wanted to determine if GAS can survive in bacteriostatic AF and if so, what transcriptional changes it undergoes to achieve this. To determine if AF had antimicrobial properties towards GAS, we tested samples collected from separate individuals at different stages of pregnancy. About half of the tested specimens did not support the growth of GAS ( Fig 1A ). Observed inhibition of GAS growth did not correlate with the gestation period (data not shown), and was instead patient specific and influenced by unknown factors. Visual inspection of AF specimens did not allow determination of the presence of meconium. Growth of GAS in AF was not restricted to the serotype M28 strain, as serotype M1 strain MGAS5005 grew at a comparable density to the M28 strain in one of the individual growth-positive specimens (data not shown). In conclusion, unlike many other bacteria, GAS can survive and grow in some AF specimens, which could have important implications for its ability to cause postpartum infections. A . Individual specimens of AF support growth of GAS at various levels after 24 h of incubation; initial inoculum ∼10 4 CFU/ml. B . Growth densities of GAS (CFU/ml) in THY and AF. To further characterize the growth of GAS in AF, we pooled all AF specimens that supported growth of GAS and performed growth curves with two different starting inocula and compared it to GAS grown in laboratory medium (THY) ( Fig. 1B ). Interestingly, GAS grown in AF reached similar density (around 2×10 7 CFU/ml) in stationary phase, despite a three-fold difference in starting inocula. Similar cell density was observed after 48h of incubation in AF. This suggests that the limited nutrient availability of AF could not sustain higher density growth. MICROARRAY ANALYSIS: GENERAL QUANTITATIVE TRENDS IN RESPONSE TO AF To characterize the transcriptional response of GAS grown in AF we utilized an ex vivo microarray approach that has been used previously to characterize the interactions of GAS with various environments such as blood and saliva [10] , [11] . We detected 859 differentially expressed genes fulfilling the criteria of differentially expressed gene (∼49% of genes present on the array). Over 250 genes were differentially expressed in ML and LL phases and the number of differentially expressed genes increased and reached maximum in S phase ( Figures 2 and 3 ). The majority of these genes in ML and LL phases were up regulated rather than down regulated. This differs from the response of GBS grown in AF [19] , in which the majority of genes are down regulated when compared to laboratory conditions and the bulk of changes are observed during the transition from logarithmic to stationary phase [19] . The complete list of transcriptional changes in GAS is shown in Table S1 and comparison of gene expression between GAS and GBS in Table S2 . Upward arrows represent the number of transcripts with increased expression in AF in ML, LL and S phases; the downward arrows represent the number of transcripts with increased expression in THY (down regulated in AF) in ML, LL and S phases. Intersections of the Venn diagram indicate number of differentially expressed genes during more than one growth phase. Each dot represents a single transcript and its coordinates are the average level of expression in THY (x-axis) and AF (y-axis). The dotted lines denote 2-fold change in transcription. Transcripts below the lower dotted line are more highly expressed in THY, transcripts above the upper dotted line are more highly expressed in AF. Thick black lines denote 10-fold differences in transcript level between the studied conditions. EXPRESSION OF VIRULENCE FACTORS Because GAS causes severe invasive postpartum diseases, we were interested in determining which virulence factors exhibited a change in expression in response to AF. Surprisingly, with the exception of CAMP factor, streptodornase, and one of the enterotoxins ( Table 1 ), we did not detect up regulation of virulence factor expression. However, we did detect massive down regulation of genes encoding proteins involved in adhesion, such as multiple fibronectin, collagen and laminin binding proteins, M protein, the gene encoding R28 protein ( M28_Spy1336 ), and streptolysin S. Down regulation of multiple adhesins and cell surface proteins could be a mechanism to evade the host immune response. The genes encoding two peptidases that interact with the host immune response, C5A peptidase and SpyCEP, were expressed at much lower levels in AF than in THY ( Table 1 ). C5A peptidase has been also shown to facilitate fibronectin-independent invasion of epithelial cells [30] . Similar down regulation of adhesins and capsule was observed in GBS when grown in AF [19] . Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. R28 is an adhesin encoded by the RD2 element present in MGAS6180 and several other GAS strains [5] . It is a known virulence factor that increases attachment of GAS to cervical cells [31] . Its down regulation might be connected to down regulation of M28_Spy1337 , which encodes a putative regulator; however, this has yet to be tested experimentally. In addition to R28, we observed an increase in transcription levels for multiple genes encoded by RD2 ( Table 2 ). The RD2 element has been suggested to be involved in pathogenesis and adaptation to specific environments [5] . Interestingly, a large number of RD2 genes differed in their expression among biological replicates; therefore the calculated P value in many cases was greater than 0.05. Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. +: P<0.05. TABLE: Differential expression of genes encoding known GAS virulence factors upon contact with AF. 6180 SF370 Locus ML LL S Descriptions M28_Spy0105 −4.20 −12.76 −28.84 Fibronectin-binding protein M28_Spy0107 - −2.49 −9.14 −7.83 Fibronectin-binding protein M28_Spy0109 SPy0128 - −2.33 −5.79 −5.36 Fibronectin-binding protein M28_Spy0113 −2.49 −2.64 −16.21 Collagen adhesion protein M28_Spy0754 SPy1054 - −2.41 −1.82 Collagen-like surface protein M28_Spy1675 sclA −167.84 −13.82 −2.83 Collagen-like surface protein M28_Spy1696 SPy2007 lmb −2.90 −5.03 Laminin-binding surface protein M28_Spy1702 SPy2018 emm −21.63 −3.84 M protein M28_Spy1715 −53.54 −8.97 −3.47 Fibronectin-binding protein M28_Spy1716 −75.85 −15.05 −5.01 Fibronectin-binding protein M28_Spy1336 −53.13 −90.92 −133.85 R28 protein M28_Spy0139 SPy0167 slo −45.03 2.68 Streptolysin O M28_Spy0540 SPy0738 sagA −2.06 Streptolysin S precursor M28_Spy0541 SPy0739 sagB −12.20 Streptolysin S biosynthesis protein M28_Spy0542 SPy0740 sagC −18.65 Streptolysin S biosynthesis protein M28_Spy0543 SPy0741 sagD −15.04 Streptolysin S biosynthesis protein M28_Spy0544 SPy0742 sagE −15.65 Streptolysin S biosynthesis protein M28_Spy0545 SPy0743 sagF −15.06 Streptolysin S biosynthesis protein M28_Spy0546 SPy0744 sagG −18.88 Streptolysin S export ATP-binding protein M28_Spy0547 SPy0745 sagH −16.89 Streptolysin S export protein M28_Spy0548 SPy0746 sagI −14.21 Streptolysin S export protein M28_Spy0180 SPy0212 speG −2.59 Enterotoxin M28_Spy0969 2.53 Enterotoxin M28_Spy0953 SPy1273 cfa 15.18 2.52 cAMP factor M28_Spy0968 SPy1436 spd3 2.26 Streptodornase (EC 3.1.21.1) M28_Spy0329 SPy0416 Spy CEP −16.21 −2.50 Endopeptidase lactocepin M28_Spy1700 SPy2010 scpA −47.34 −2.64 C5A peptidase precursor (EC 3.4.21.-) TABLE: Differential expression of RD2 genes in response to AF. Gene ML P LL S Putative function note M28_Spy1304 10.19 6.76 16.10 + Hypothetical Protein M28_Spy1305 2.39 + 2.43 + 1.75 + Hypothetical membrane protein M28_Spy1306 10.06 + 7.60 + 2.47 Cell surface protein Virulence M28_Spy1307 5.13 3.98 + 1.08 Hypothetical exported protein Virulence M28_Spy1308 5.52 2.65 3.81 + Hypothetical exported protein Virulence M28_Spy1309 1.54 + 1.71 + 1.70 + Hypothetical protein M28_Spy1310 3.41 3.13 + 1.78 Membrane protein M28_Spy1311 Not detected M28_Spy1312 Not detected M28_Spy1313 8.70 6.23 2.28 Hypothetical membrane protein M28_Spy1314 5.17 4.37 + 3.00 hypothetical protein M28_Spy1315 5.69 7.31 + 3.42 Hypothetical protein M28_Spy1316 9.67 8.45 6.03 Hypothetical protein M28_Spy1317 35.90 12.95 3.67 Hypothetical protein M28_Spy1318 3.81 2.69 6.31 + Hypothetical protein M28_Spy1319 Not detected M28_Spy1320 11.20 36.55 + 10.89 + Hypothetical cytosolic protein M28_Spy1321 Not detected M28_Spy1322 6.26 4.41 2.37 FtsK SpoIIIE family M28_Spy1323 9.05 + 6.88 + 1.61 Hypothetical cytosolic protein M28_Spy1324 5.80 7.41 + 2.68 Hypothetical cytosolic protein M28_Spy1325 3.99 + 2.28 1.72 Cell surface protein Virulence M28_Spy1326 2.18 + 1.08 −1.29 + M like protein Virulence M28_Spy1327 18.65 6.43 4.84 Hypothetical cytosolic protein M28_Spy1328 Not detected M28_Spy1329 12.91 5.16 2.98 Transcriptional Cro CI regulator M28_Spy1330 1.80 + 1.75 + 2.23 + Transcriptional Cro CI regulator M28_Spy1331 2.22 + 2.51 + 4.28 + Hypothetical cytosolic protein M28_Spy1332 2.42 + 2.50 + 8.66 + Hypothetical exported protein Virulence M28_Spy1333 1.89 + 1.69 + 5.46 + Hypothetical cytosolic protein M28_Spy1334 1.74 + 2.35 + 6.34 + DNA-damage-inducible protein J M28_Spy1335 1.20 1.36 3.20 Transposase M28_Spy1336 −53.13 + −90.92 + −133.85 + R28 Cell surface protein Virulence M28_Spy1337 −5.18 + −8.50 + −7.93 + Transcriptional regulator STRESS RESPONSE OF GAS AND GBS TO AF In contrast to GBS, which does not increase transcription of genes encoding proteins involved in the stress response [19] , GAS activates multiple genes involved in this process. We observed increased transcription of the genes encoding proteolytic complex composed of ATPase and catalytic subunits ( clpP , clpE , clpX , and clpL ) known to be stress effectors in streptococci [32] , [33] , the GroEL and GroES chaperonins, members of the Gls24 family of stress proteins (stress and starvation inducible genes in Enterococcus faecalis , [34] ), and a putative GTP pyrophosphokinase ( Table 3 ). Expression of the gene M28_Spy1562 that encodes a putative stress protein, was dramatically decreased in AF; however, its function in GAS is unknown. We also observed lowered expression of the relA gene which is major regulator of stringent control in GAS [35] . Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. TABLE: Differential expression of stress response genes in response to AF. 6180 SF370 Locus ML LL S Descriptions M28_Spy0317 SPy0395 clpP 3.01 proteolytic subunit clpP M28_Spy1179 SPy1509 clpE 2.01 2.64 2.04 ATP-binding subunit clpE M28_Spy0659 SPy0873 - 2.05 GTP pyrophosphokinase M28_Spy0671 clpX −6.23 ATP-binding subunit clpX M28_Spy0674 SPy0888 clpL 3.29 6.32 ATP-binding subunit clpL M28_Spy0943 SPy1260 - 2.66 General stress protein, Gls24 family M28_Spy0945 SPy1262 - 2.59 General stress protein, Gls24 family M28_Spy1286 SPy1557 msrA 3.73 2.41 Peptide methionine sulfoxide reductase msrA M28_Spy0755 SPy1055 msrB 5.36 4.95 8.23 Peptide methionine sulfoxide reductase msrB M28_Spy1503 SPy1780 - 2.71 Universal stress protein family M28_Spy1562 - −102.42 −17.90 Universal stress protein family M28_Spy0659 SPy0873 - 2.05 GTP pyrophosphokinase M28_Spy1674 SPy1981 relA −2.11 −2.15 GTP pyrophosphokinase M28_Spy1747 SPy2070 groEL 2.34 60 kDa chaperonin GROEL M28_Spy1748 SPy2072 groES 2.36 10 kDa chaperonin GROES M28_Spy1751 SPy2077 csp 2.24 8.50 Cold shock protein REGULATORY EVENTS DURING GROWTH IN AF We observed a large number of significant changes in transcription of regulatory genes ( Table S1 ). Because the exact functions of many of these are unknown, it is impossible to predict the significance of these changes. However, we did detect changes in expression of known GAS regulators ( Table 4 ) such as RofA/RALP that are involved in the regulation of virulence factor expression, namely adhesins [36] . Down regulation of rofA in response to AF might be partially responsible for the observed decreases in the transcription of the genes encoding fibronectin binding proteins. The decreased gene expression of the regulator ahrC.2 may be responsible for the observed changes in expression of genes involved in arginine metabolism (see below). Two other differentially expressed regulators were recently shown to be involved in GAS pathogenesis. The first, MtsR, is a regulator of ion transport and is involved in the development of necrotizing fasciitis [37] , [38] The second, CcpA, links GAS virulence and carbohydrate metabolism [18] . In addition to individual regulators, we detected differential expression of seven (of 13) two component systems (TCSs) encoded by GAS. In the absence of regulation by alternative sigma factors in GAS, it is believed that concerted activity of regulons and TCSs is responsible for reaction of GAS to the environment. FasBCA and ihk/irr were shown to be involved in regulation of GAS pathogenesis. FasBCA controls expression of streptokinase, streptolysin S, and fibronectin binding proteins [39] , [40] . The Ihk/Irr system is involved in GAS survival upon contact with human PMNs [12] . Circuits regulated by two other two component systems, M28_Spy0761/2 (SPy1061/2 in SF370 strain) and M28_Spy0807/8 (SPy1106/7 in SF370 strain), were studied by microarray analysis [17] and were shown to be involved in regulation of genes involved in carbohydrate and malate utilization, respectively. M28_Spy0919/20, M28_Spy1346/7 and M28_Spy1373/4 (SPy1236/7, SPy1587/8, SPy1621/2 in SF370 strain, respectively) have not been characterized thus far. Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. TABLE: Differential expression of selected regulatory systems in response to AF. 6180 SF370 Locus ML LL S Descriptions M28_Spy0104 SPy0124 rofA −2.09 −3.56 −2.69 Transcriptional regulator RofA M28_Spy0122 SPy0146 sloR −11.53 −13.76 Transcriptional regulator pfoR M28_Spy0198 SPy0242 fasB −3.31 Sensory transduction protein kinase FasB M28_Spy0199 SPy0244 fasC −2.08 −2.09 −4.77 Sensory transduction protein kinase FasC M28_Spy0200 SPy0245 fasA −3.61 Response regulator FasA M28_Spy0356 SPy0450 mtsR 3.96 Iron-dependent repressor M28_Spy0412 SPy0514 ccpA −3.65 Catabolite control protein A M28_Spy0465 SPy0584 ptsK 2.66 HPR(SER) kinase M28_Spy0761 SPy1061 - −4.83 Two-component sensor kinase yesM M28_Spy0762 SPy1062 - −3.19 Two-component response regulator yesN M28_Spy0807 SPy1106 dpiA 2.09 Transcriptional regulatory protein dpiA M28_Spy0808 SPy1107 dpiB 2.16 Sensor kinase dpiB M28_Spy0919 SPy1236 ciaH −3.35 Sensor protein ciaH M28_Spy0920 SPy1237 ciaR −2.58 Transcriptional regulatory protein ciaR M28_Spy1215 SPy1549 ahrC.2 −16.22 Arginine repressor, argR M28_Spy1346 SPy1587 - −4.45 Two-component response regulator yesN M28_Spy1347 SPy1588 - −3.03 Two-component sensor kinase yesM M28_Spy1373 SPy1621 yvqC 2.05 Two-component response regulator yvqC M28_Spy1374 SPy1622 yvqE 2.28 3.93 Two-component sensor protein yvqE M28_Spy1708 SPy2026 ihk −1.96 Two component system histidine kinase M28_Spy1709 SPy2027 irr −1.58 Two-component response regulator METABOLIC ADAPTATION TO AF ENVIRONMENT A recently performed transcriptional analysis of GBS grown in AF revealed dramatic changes in expression of genes that control metabolism of carbohydrates, amino acids, and nucleotides [19] , which presumably reflects an adaptive response to limited nutrient availability. We observed similar trends in the metabolic response of GAS to AF, with the majority of differences occurring in expression of genes involved in carbohydrate utilization ( Table S2 ). In contrast to GBS that up regulates genes involved in carbohydrate utilization, GAS down regulates genes belonging to this category. Clear examples are the M28_Spy1036-1048 ( mal genes), M28_Spy1349-1354, M28_Spy1438-1445 ( lac.1 genes), and M28_Spy1622-1629 ( lac.2 genes) loci ( Table 5 ). The Mal locus has been shown to be involved in GAS persistence in the oropharynx [41] , and lac loci are not only involved in fermentation and energy production via the tagatose pathway, but also link metabolism and the regulation of virulence [42] . Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. Another category of metabolic genes affected by growth in AF were genes involved in protein and amino acid utilization. We observed differential expression of multiple proteases, and di- and oligopeptide transport systems ( Table 6 ). Similarly to GBS, we observed up regulation of genes involved in uptake and utilization of branched chain amino acids (BCAA, valine, leucine, and isoleucine). GBS is auxotrophic in respect to BCAA and mobilizes all transport systems to maximize utilization from AF [19] ; GAS could possibly employ the same mechanism to maximize nutrient utilization. Values represent fold change in expression in AF at ML, LL, and S growth phases compared to expression in THY medium. The most dramatic changes in gene expression were observed in genes encoding enzymes of the arginine deiminase pathway, which were down regulated almost 900-fold upon contact with AF ( Table 6 ). The arginine deiminase pathway allows utilization of arginine as a carbon and energy source [43] and plays a role in the modification of the environmental acidity [44] , [45] . Arginine deiminase from the GAS Manfredo strain is also a potent inhibitor of the proliferation of peripheral blood mononuclear cells [46] . However, arginine deiminase is not only an intracellular enzyme involved in the aforementioned processes. It can be also found on the GAS cell surface [47] and antibodies against this protein have been recently reported to protect mice against GAS infection (Walker MJ, Henningham A, Cork A, Cole JN, Ramachandran V et al. (2008) Group A Anchorless Surface proteins. XVII Lancefield International Symposium on Streptococci and Streptococcal Diseases O9.2; Henningham A, Batzloff M, Cole JN, Gillen C, Hartas J et al. (2008) Protection Against lethal Streptococcus pyogenes challenge following vaccination with anchorless cell wall-associated proteins. XVII Lancefield International Symposium on Streptococci and Streptococcal Diseases P54). It is possible that the lack of arginine deiminase on the surface is linked to decreased recognition by the host immune response, which would be consistent with the observed down regulation of adhesins and other major surface proteins. Interestingly, fetal urine (which is a major component of AF) flow and composition is modulated by arginine levels [22] , therefore bacterial arginine metabolism could be linked to AF dynamics. Arginine metabolism is linked via carbamate kinase to another pathway – nucleotide synthesis ( Figure 4 ). We observed dramatic up regulation of genes involved in purine and pyrimidine nucleotide biosynthesis pathways and down regulation of genes encoding enzymes involved in salvage pathways ( Table 7 ). The extent of changes in GAS correlates well with changes detected in GBS [19] , and almost all of the enzymes in the nucleotide metabolic pathways undergo the same directional changes ( Figure 4 ), what suggests direct influence of the AF environment. Both GAS and GBS exhibit similar changes in the expression of genes encoding enzymes involved in nucleotide biosynthesis. Changes in transcription of GBS genes from [19] , changes in transcription of GAS genes, this work. Light green: genes down regulated 2 to 5 fold upon contact with AF; dark green: above 5 fold. Light orange: genes up regulated 2 to 5 fold upon contact with AF; dark orange: above 5 fold. R5P, ribose 5-phosphate; PRPP, phosphoribosylpyrophosphate; PRA, 5-phospho-b-D-ribosylamine; GAR, 5′-phosphoribosylglycinamide; FGAR, 5′-phosphoribosyl-N-formylglycinamide; FGAM, 5′-phosphoribosyl-N-formylglycinamidine; AIR, 5′-phosphoribosyl-5-aminoimidazole; NCAIR, 5′-phosphoribosyl-5-carboxyaminoimidazole; CAIR, 5′-phosphoribosyl-5-aminoimidazole-4-carboxylate; SAICAR, 5′-phosphoribosyl-4-(N-succino-carboxamide)-5-aminoimidazole; AICAR, 5′-phosphoribosyl-4-carboximide-5-aminoimidazole ribonucleotide; FAICAR, 5′-phosphoribosyl-4-carboximide-5-formaminoimidazole; IMP, inosine 5′-monophosphate; XMP, xanthosine monophosphate; GMP, guanosine monophosphate; GTP, guanosine triphosphate; sAMP, adenylosuccinate; AMP, adenosine monophosphate; ATP, adenosine triphosphate. Values represent fold change in expression in AF at ML, LL, and S growth phases compared to the expression in THY medium. Samant et al. [48] recently showed that multiple enzymes involved in nucleotide metabolism are essential for growth of Escherichia coli in human serum, and a bacterial growth defect can be rescued by the addition of nucleotides to the serum. To test if a lack of nucleotides or arginine/ornithine in the AF is a growth limiting factor, we tested growth of GAS in AF with the addition of selected amino acids and nucleotides (arginine, ornithine, adenine, xanthine, and uracyl at concentrations corresponding to minimal chemically defined media (CDM) concentrations for GAS [49] ). The observed culture densities after overnight growth did not increase compared to the AF without any supplements ( Figure 5 ). Therefore, the lack of arginine and nucleotides in AF is not a limiting factor for growth of GAS and up regulation of the nucleotide synthesis pathway has a distinct function from providing material for DNA synthesis. Multiple reports have suggested a connection between nucleotide metabolism and bacterial virulence [50] . Mereghetti et al. recently reported changes in nucleotide metabolism in GBS during growth in blood and as an effect of a temperature switch [51] , [52] . Cell densities of GAS cultures grown in pooled AF for 24 hours with addition of amino acids (arginine, ornithine) and nucleotides (xanthine, uracil, and adenine) at the concentration that supports growth of GAS in minimal CDM [49] . TABLE: Differential expression of selected genes responsible for transport and metabolism of carbohydrates. 6180 SF370 Locus ML LL S Descriptions M28_Spy0757 SPy1057 - −3.86 −11.47 −18.53 PTS system, mannose fructose family M28_Spy0759 SPy1059 ptsC −4.04 −7.65 −13.42 PTS system, mannose fructose family M28_Spy0958 SPy1280 glmS −2.80 −2.01 Glucosamine–fructose-6-phosphate aminotransferase M28_Spy1036 SPy1291 glgP −2.16 Maltodextrin phosphorylase M28_Spy1037 SPy1292 malM −14.96 4-alpha-glucanotransferase M28_Spy1039 SPy1294 malE −4.94 Maltose maltodextrin-binding protein M28_Spy1041 SPy1296 malG 2.19 Maltose transport system permease protein M28_Spy1044 SPy1299 malD −34.73 Maltodextrin transport system permease protein M28_Spy1045 SPy1301 malC −38.81 Maltodextrin transport system permease protein M28_Spy1046 SPy1302 amyA −82.63 Cyclodextrin glucanotransferase M28_Spy1047 SPy1304 amyB 2.06 −24.86 Neopullulanase M28_Spy1048 SPy1306 malX −37.14 Maltose maltodextrin-binding protein M28_Spy1349 SPy1592 - −42.74 Sugar-binding protein M28_Spy1350 SPy1593 - −13.77 Sugar transport system permease protein M28_Spy1351 SPy1595 - −7.07 Sugar transport system permease protein M28_Spy1354 SPy1599 - −2.17 Beta-glucosidase M28_Spy1438 SPy1704 lacD.1 −49.45 Tagatose-bisphosphate aldolase M28_Spy1440 SPy1707 lacB.1 −170.54 Galactose-6-phosphate isomerase lacB subunit M28_Spy1441 SPy1708 lacA.1 −100.49 Galactose-6-phosphate isomerase lacA subunit M28_Spy1442 SPy1709 - 2.40 PTS system, galactose-specific IIC component M28_Spy1443 SPy1710 - −26.62 PTS system, galactose-specific IIB component M28_Spy1444 SPy1711 - −57.34 PTS system, galactose-specific IIA component M28_Spy1445 SPy1712 lacR.1 −2.47 Lactose phosphotransferase system repressor M28_Spy1622 SPy1916 lacG −67.36 6-phospho-beta-galactosidase M28_Spy1624 SPy1918 lacF −8.85 PTS system, lactose-specific IIA component M28_Spy1625 SPy1919 lacD.2 −122.01 Tagatose-bisphosphate aldolase M28_Spy1626 SPy1921 lacC.2 −55.33 Tagatose-6-phosphate kinase M28_Spy1627 SPy1922 lacB.2 −21.89 Galactose-6-phosphate isomerase lacB subunit M28_Spy1628 SPy1923 lacA.2 −69.34 Galactose-6-phosphate isomerase lacA subunit M28_Spy1629 SPy1924 lacR.2 −3.72 Lactose phosphotransferase system repressor M28_Spy1668 SPy1972 pulA −5.30 Pullulanase M28_Spy1767 SPy2096 dexS −6.18 −39.01 Trehalose-6-phosphate hydrolase M28_Spy1768 SPy2097 - −8.81 −43.06 PTS system, trehalose-specific IIBC component TABLE: Differential expression of genes involved in the transport and metabolism of amino acids, peptides, and amines. 6180 SF370 Locus ML LL S Descriptions Proteases M28_Spy0463 SPy0581 - −2.95 Metallopeptidase, SprT family M28_Spy0470 SPy0590 - −2.23 −2.82 Peptidase family U32 M28_Spy0471 SPy0591 - −2.10 Peptidase family U32 M28_Spy0572 SPy0775 - 2.31 Neutral zinc metallopeptidase family M28_Spy1136 SPy1402 - 34.77 Peptidase family S11 M28_Spy1397 SPy1651 pepC −1.98 Aminopeptidase C M28_Spy1565 SPy1858 pepXP 2.31 4.45 Xaa-Pro dipeptidyl-peptidase M28_Spy1744 SPy2066 - −4.28 −22.44 Dipeptidase A (EC 3.4.13.-) M28_Spy1766 SPy2095 pepO −2.78 Oligoendopeptidase O (EC 3.4.24.-) Arginine metabolism M28_Spy0575 SPy0778 - −2.35 Arginine-binding protein M28_Spy1176 SPy1506 artP 2.95 2.12 2.07 Arginine transport ATP-binding protein M28_Spy1177 SPy1507 artQ 2.50 2.08 Arginine transport system permease protein M28_Spy1208 SPy1541 arcC −8.01 −877.27 Carbamate kinase M28_Spy1209 SPy1542 - −199.49 Xaa-His dipeptidase M28_Spy1210 SPy1543 - −2.55 −191.92 Arginine ornithine antiporter M28_Spy1211 SPy1544 arcB −4.96 −212.09 Ornithine carbamoyltransferase M28_Spy1213 SPy1547 arcA −8.87 −712.24 Arginine deiminase Branched chain amino acids M28_Spy0266 SPy0323 braB 5.13 5.26 2.21 Branched-chain amino acid carrier protein M28_Spy0693 SPy0911 bcaT 2.13 3.48 Branched-chain amino acid aminotransferase Di- and oligopeptide transport M28_Spy1689 SPy2000 dppA −4.23 −2.68 Dipeptide-binding protein M28_Spy1690 SPy2001 dppB −3.39 −2.70 Dipeptide transport system permease protein M28_Spy1691 SPy2002 dppC −4.57 −2.82 −2.61 Dipeptide transport system permease M28_Spy1692 SPy2003 dppD −4.19 −2.58 −2.46 Dipeptide transport ATP-binding protein M28_Spy1693 SPy2004 dppE −4.21 −2.76 Dipeptide transport ATP-binding protein M28_Spy0245 SPy0294 oppB 2.55 Oligopeptide transport system permease M28_Spy0246 SPy0295 oppC 2.01 Oligopeptide transport system permease M28_Spy0247 SPy0296 oppD 1.75 Oligopeptide transport ATP-binding M28_Spy0248 SPy0297 oppF 1.89 Oligopeptide transport ATP-binding TABLE: Differential expression of selected genes involved in nucleotide metabolism upon contact with AF. 6180 SF370 Locus ML LL S Descriptions M28_Spy0022 SPy0024 - 36.60 10.73 35.84 Phosphoribosylaminoimidazole-succinocarboxamide synthase M28_Spy0024 SPy0026 purF 24.03 10.89 13.45 Amidophosphoribosyltransferase M28_Spy0026 SPy0028 purN 37.86 18.63 17.69 Phosphoribosylglycinamide formyltransferase M28_Spy0027 purH 17.83 3.68 3.85 Phosphoribosylaminoimidazolecarboxamide formyltransferase M28_Spy0029 SPy0032 purD 15.56 9.89 11.31 Phosphoribosylamine-glycine ligase M28_Spy0030 SPy0033 purE 16.52 7.50 11.42 Phosphoribosylaminoimidazole carboxylase carboxyltransferase M28_Spy0031 SPy0034 purK 6.05 11.19 Phosphoribosylaminoimidazole carboxylase NCAIR mutase M28_Spy0064 SPy0074 adk −8.25 Adenylate kinase M28_Spy0134 SPy0160 purA 3.17 Adenylosuccinate synthetase M28_Spy0193 SPy0235 - −2.67 Deoxyuridine 5 -triphosphate nucleotidohydrolase M28_Spy0316 SPy0392 upp −2.43 Uracil phosphoribosyltransferase M28_Spy0334 SPy0425 nrdF.1 −5.27 Ribonucleoside-diphosphate reductase beta chain M28_Spy0335 SPy0426 nrdI −4.58 NrdI protein M28_Spy0336 SPy0427 nrdE.1 −2.37 Ribonucleoside-diphosphate reductase alpha chain M28_Spy0597 SPy0803 cmk 2.59 Cytidylate kinase M28_Spy0620 SPy0831 pyrP 6.66 Uracil permease M28_Spy0622 SPy0833 carA 4.79 −2.17 Carbamoyl-phosphate synthase small chain M28_Spy0624 SPy0835 carB 5.93 −2.87 Carbamoyl-phosphate synthase large chain M28_Spy0658 SPy0872 - 68.19 15.18 11.50 5 -nucleotidase M28_Spy0668 SPy0882 thyA −3.66 Thymidylate synthase M28_Spy0679 SPy0894 deoD2 −2.85 Purine nucleoside phosphorylase M28_Spy0683 SPy0900 pyrF 3.45 Orotidine 5 -phosphate decarboxylase M28_Spy0684 SPy0901 pyrE 4.03 Orotate phosphoribosyltransferase M28_Spy0689 SPy0907 pyrC 2.82 2.39 2.51 Dihydroorotase M28_Spy0708 SPy0927 apt −2.13 Adenine phosphoribosyltransferase M28_Spy0821 SPy1123 - 2.04 Ribose-phosphate pyrophosphokinase M28_Spy0831 SPy1135 guaC 68.20 23.60 95.96 GMP reductase M28_Spy0832 SPy1136 xpt 40.85 90.15 Xanthine phosphoribosyltransferase M28_Spy0833 SPy1137 - 9.77 45.75 76.46 Xanthine permease M28_Spy0897 SPy1211 rnhB 2.92 8.45 Anaerobic ribonucleoside-triphosphate reductase M28_Spy0899 SPy1213 fhs.1 5.53 4.21 Formate–tetrahydrofolate ligase M28_Spy0914 SPy1228 - 2.11 Nucleoside-binding protein M28_Spy1109 SPy1368 udk −2.04 Uridine kinase M28_Spy1118 SPy1378 nrdF.2 2.32 Ribonucleoside-diphosphate reductase beta chain M28_Spy1159 SPy1432 pyrD 2.15 Dihydroorotate dehydrogenase M28_Spy1466 SPy1736 - 5.01 3.02 5.14 Guanine-hypoxanthine permease M28_Spy1580 SPy1869 udp −2.83 Uridine phosphorylase M28_Spy1599 SPy1894 pyrG −2.64 CTP synthase M28_Spy1758 SPy2085 fhs.2 3.32 2.32 Formate–tetrahydrofolate ligase M28_Spy1773 SPy2105 nrdG −2.00 −2.45 Anaerobic ribonucleoside-triphosphate reductase activating protein M28_Spy1777 SPy2110 nrdD −2.22 −3.50 Anaerobic ribonucleoside-triphosphate reductase M28_Spy1890 SPy2206 guaB −2.28 Inosine-5 -monophosphate dehydrogenase SUMMARY Group A Streptococcus , a causative agent of postpartum invasive infections, is able to survive and multiply in AF. It is able to multiply and survive over 48h in the AF environment. The response of GAS is in many aspects similar to the response exhibited by GBS; however, on the contrary to GBS, GAS exhibits stronger stress response to the AF environment. GAS adapts to growth in AF by differential regulation of genes involved in arginine and nucleotide metabolism. In addition, GAS down regulates multiple cell surface proteins, presumably to escape host immune recognition. SUPPORTING INFORMATION Differential expression of all GAS genes in response to AF. Changes in transcription of GAS genes upon contact with amniotic fluid. All changes detected in transcription of GAS in response to amniotic fluid. Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF (orange), negative values represent down-regulated (green, better expressed in THY) genes. Rows marked grey denote transcripts not detected during the experiment. (0.62 MB XLS) Comparison of transcriptional changes between GAS and GBS grown in AF. Differential expression of GAS and GBS genes in response to AF - Changes in transcription of GAS and GBS genes upon contact with amniotic fluid. Values represent fold change in expression in amniotic fluid compared to expression in THY; ML, mid-logarithmic growth phase; LL, late-logarithmic growth phase; S, stationary growth phase; cut-off two fold change with P value less than 0.05. Positive values represent genes up-regulated in AF (orange), negative values represent down-regulated (green, better expressed in THY) genes. GBS data after reference [19] . (0.34 MB XLS) REFERENCES [1] Cunningham MW 2000 Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13 470 511 [2] Carapetis JR Steer AC Mulholland EK Weber M 2005 The global burden of group A streptococcal diseases. Lancet Infect Dis 5 685 694 [3] Pasteur L 1879 Septicemie puerperale. Bulletin de l'Academie de Medecine 8 271 274 [4] Chuang I Van BC Beall B Schuchat A 2002 Population-based surveillance for postpartum invasive group A Streptococcus infections, 1995–2000. Clin Infect Dis 35 665 670 [5] Green NM Zhang S Porcella SF Nagiec MJ Barbian KD 2005 Genome sequence of a serotype M28 strain of group A Streptococcus : potential new insights into puerperal sepsis and bacterial disease specificity. J Infect Dis 192 760 770 [6] Green NM Beres SB Graviss EA Allison JE McGeer AJ 2005 Genetic diversity among type emm28 group A Streptococcus strains causing invasive infections and pharyngitis. J Clin Microbiol 43 4083 4091 [7] Tettelin H Masignani V Cieslewicz MJ Donati C Medini D 2005 Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae : implications for the microbial “pan-genome”. Proc Natl Acad Sci U S A 102 13950 13955 [8] Mylvaganam H Bruun T Vindenes HA Langeland N Skrede S 2009 Molecular epidemiological investigation of an outbreak of invasive beta-haemolytic streptococcal infection in western Norway. Clin Microbiol Infect 15 245 252 [9] Pinho MD Melo-Cristino J Ramirez M 2006 Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness. J Clin Microbiol 44 841 846 [10] Graham MR Virtaneva K Porcella SF Barry WT Gowen BB 2005 Group A Streptococcus transcriptome dynamics during growth in human blood reveals bacterial adaptive and survival strategies. Am J Pathol 166 455 465 [11] Shelburne SA III Sumby P Sitkiewicz I Granville C DeLeo FR 2005 Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci U S A 102 16037 16042 [12] Voyich JM Sturdevant DE Braughton KR Kobayashi SD Lei B 2003 Genome-wide protective response used by group A Streptococcus to evade destruction by human polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 100 1996 2001 [13] Goldmann O von Kockritz-Blickwede M Holtje C Chhatwal GS Geffers R 2007 Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program. Infect Immun 75 4148 4157 [14] Eidelman AI Nevet A Rudensky B Rabinowitz R Hammerman C 2002 The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B Streptococcus . J Perinatol 22 467 471 [15] Pommerenke WT Taylor PW 1953 Antibacterial properties of vaginal and cervical secretions and amniotic fluid. Ann Ostet Ginecol 75 891 899 [16] Sumby P Porcella SF Madrigal AG Barbian KD Virtaneva K 2005 Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 192 771 782 [17] Sitkiewicz I Musser JM 2006 Expression microarray and mouse virulence analysis of four conserved two-component gene regulatory systems in group A Streptococcus . Infect Immun 74 1339 1351 [18] Shelburne SA III Keith D Horstmann N Sumby P Davenport MT 2008 A direct link between carbohydrate utilization and virulence in the major human pathogen group A Streptococcus . Proc Natl Acad Sci U S A 105 1698 1703 [19] Sitkiewicz I Green NM Guo N Bongiovanni AM Witkin SS 2009 Transcriptome adaptation of group B Streptococcus to growth in human amniotic fluid. PLoS One 4 e6114 [20] Sozanskii A 1961 The biochemical composition of amniotic fluid and of maternal and fetal blood at various periods of pregnancy. Biull Eksp Biol Med 51 323 326 [21] Nilsson S Ramstrom M Palmblad M Axelsson O Bergquist J 2004 Explorative study of the protein composition of amniotic fluid by liquid chromatography electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry. J Proteome Res 3 884 889 [22] Modena AB Fieni S 2004 Amniotic fluid dynamics. Acta Biomed 75 Suppl 1 11 13 [23] Beck A Bergner-Rabinowitz S Ofek I 1969 Effect of pH on in vitro phagocytosis of Streptococcus pyogenes. J Bacteriol 100 1204 1207 [24] Galask RP Snyder IS 1970 Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol 106 59 65 [25] Larsen B Snyder IS Galask RP 1974 Bacterial growth inhibition by amniotic fluid. I. In vitro evidence for bacterial growth-inhibiting activity. Am J Obstet Gynecol 119 492 496 [26] Larsen B Snyder IS Galask RP 1974 Bacterial growth inhibition by amniotic fluid. 2. Reversal of amniotic fluid bacterial growth inhibition by addition of a chemically defined medium. Am J Obstet Gynecol 119 497 501 [27] Evans HE Levy E Glass L 1977 Effect of amniotic fluid on bacterial growth. Obstet Gynecol 49 35 37 [28] Ahn YJ Park SK Oh JW Sun HY Shin SH 2004 Bacterial growth in amniotic fluid is dependent on the iron-availability and the activity of bacterial iron-uptake system. J Korean Med Sci 19 333 340 [29] Tran SH Caughey AB Musci TJ 2003 Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol 189 746 750 [30] Purushothaman SS Park HS Cleary PP 2004 Promotion of fibronectin independent invasion by C5a peptidase into epithelial cells in group A Streptococcus . Indian J Med Res 119 Suppl 44 47 [31] Stalhammar-Carlemalm M Areschoug T Larsson C Lindahl G 1999 The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol Microbiol 33 208 219 [32] Nair S Poyart C Beretti JL Veiga-Fernandes H Berche P 2003 Role of the Streptococcus agalactiae ClpP serine protease in heat-induced stress defence and growth arrest. Microbiology 149 407 417 [33] Robertson GT Ng WL Foley J Gilmour R Winkler ME 2002 Global transcriptional analysis of clpP mutations of type 2 Streptococcus pneumoniae and their effects on physiology and virulence. J Bacteriol 184 3508 3520 [34] Giard JC Rince A Capiaux H Auffray Y Hartke A 2000 Inactivation of the stress- and starvation-inducible gls24 operon has a pleiotrophic effect on cell morphology, stress sensitivity, and gene expression in Enterococcus faecalis . J Bacteriol 182 4512 4520 [35] Malke H Steiner K McShan WM Ferretti JJ 2006 Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol 296 259 275 [36] Kreikemeyer B Beckert S Braun-Kiewnick A Podbielski A 2002 Group A streptococcal RofA-type global regulators exhibit a strain-specific genomic presence and regulation pattern. Microbiology 148 1501 1511 [37] Beres SB Richter EW Nagiec MJ Sumby P Porcella SF 2006 Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus. Proc Natl Acad Sci U S A 103 7059 7064 [38] Olsen RJ Sitkiewicz I Ayeras AA Gonulal VE Cantu C 2010 Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis. Proc Natl Acad Sci U S A 107 888 893 [39] Kreikemeyer B Boyle MD Buttaro BA Heinemann M Podbielski A 2001 Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule. Mol Microbiol 39 392 406 [40] Steiner K Malke H 2002 Dual control of streptokinase and streptolysin S production by the covRS and fasCAX two-component regulators in Streptococcus dysgalactiae subsp. equisimilis . Infect Immun 70 3627 3636 [41] Shelburne SA III Keith DB Davenport MT Horstmann N Brennan RG 2008 Molecular characterization of group A Streptococcus maltodextrin catabolism and its role in pharyngitis. Mol Microbiol 69 436 452 [42] Loughman JA Caparon MG 2006 A novel adaptation of aldolase regulates virulence in Streptococcus pyogenes . EMBO J 25 5414 5422 [43] Pierce WA White AG 1955 Arginine and glucose metabolism in a strain of Streptococcus pyogenes . J Bacteriol 69 230 231 [44] Degnan BA Fontaine MC Doebereiner AH Lee JJ Mastroeni P 2000 Characterization of an isogenic mutant of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal acid glycoprotein. Infect Immun 68 2441 2448 [45] Quivey RG Kuhnert WL Hahn K 2001 Genetics of acid adaptation in oral streptococci. Crit Rev Oral Biol Med 12 301 314 [46] Degnan BA Palmer JM Robson T Jones CE Fischer M 1998 Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun 66 3050 3058 [47] Lei B Mackie S Lukomski S Musser JM 2000 Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect Immun 68 6807 6818 [48] Samant S Lee H Ghassemi M Chen J Cook JL 2008 Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog 4 e37 [49] van de Rijn I Kessler RE 1980 Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun 27 444 448 [50] Pettersson J Schrumpf ME Raffel SJ Porcella SF Guyard C 2007 Purine salvage pathways among Borrelia species. Infect Immun 75 3877 3884 [51] Mereghetti L Sitkiewicz I Green NM Musser JM 2008 Extensive adaptive changes occur in the transcriptome of Streptococcus agalactiae (group B Streptococcus ) in response to incubation with human blood. PLoS One 3 e3143 [52] Mereghetti L Sitkiewicz I Green NM Musser JM 2008 Remodeling of the Streptococcus agalactiae transcriptome in response to growth temperature. PLoS One 3 e2785